Alseres Pharmaceuticals, Inc. (ALSE) Research

Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.

Market snapshot

Symbol
ALSE
Price
$0.01
Day change
+100.00%
Market cap
$398.3K
P/E ratio
-0.00x
52-week range
0.005-0.01
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Achiko AG (ACHKF)
  • Digicann Ventures Inc. (AGFAF)
  • Aquarius Surgical Technologies Inc. (AQQRF)
  • Evolva Holding S.A. (ELVAY)
  • FluroTech Ltd. (FLURF)
  • Hemogenyx Pharmaceuticals Plc (HOPHF)
  • TuHURA Biosciences, Inc. (HURA)
  • Kiromic BioPharma, Inc. (KRBP)

Recent insider activity

  • LANGER ROBERT — A-Award (25000 shares) on 2009-01-14
  • PRESTON JOHN T — A-Award (25000 shares) on 2009-01-14
  • SAVAS PETER G — A-Award (950000 shares) on 2009-01-14
  • SAVAS PETER G — D-Return (400000 shares) on 2009-01-14
  • SAVAS PETER G — D-Return (350000 shares) on 2009-01-14

Open Alseres Pharmaceuticals, Inc. (ALSE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.